Development
Taysha Gene Therapies, Inc.
TSHA
$2.84
-$0.04-1.39%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 164.28M | 45.08M | 63.43M | 87.88M | 34.31M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.73M | 3.33M | 2.97M | 2.53M | 2.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.80M | 5.70M | 5.97M | 6.01M | 6.28M |
| Total Current Assets | 171.81M | 54.12M | 72.36M | 96.42M | 43.00M |
|
|
|||||
| Total Current Assets | 171.81M | 54.12M | 72.36M | 96.42M | 43.00M |
| Net Property, Plant & Equipment | 21.02M | 24.49M | 25.29M | 25.91M | 63.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.94M | 2.94M | 3.95M | 3.95M | 4.51M |
| Total Assets | 195.77M | 81.54M | 101.60M | 126.28M | 111.47M |
|
|
|||||
| Total Accounts Payable | 7.52M | 10.77M | 9.00M | 10.95M | 15.25M |
| Total Accrued Expenses | 11.37M | 17.31M | 14.05M | 14.04M | 14.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.54M | 1.64M | 1.75M | 1.52M | -- |
| Total Finance Division Other Current Liabilities | 160.02M | 20.93M | 29.65M | 36.29M | 3.24M |
| Total Other Current Liabilities | 160.02M | 20.93M | 29.65M | 36.29M | 3.24M |
| Total Current Liabilities | 180.45M | 50.64M | 54.46M | 62.79M | 33.14M |
|
|
|||||
| Total Current Liabilities | 180.45M | 50.64M | 54.46M | 62.79M | 33.14M |
| Long-Term Debt | 38.55M | 38.35M | 38.16M | 37.97M | 37.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.94M | 20.45M | 20.94M | 20.44M | 25.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.95M | 9.21M | 3.00M | 4.13M | 3.93M |
| Total Liabilities | 244.88M | 118.66M | 116.55M | 125.33M | 100.34M |
|
|
|||||
| Common Stock & APIC | 511.63M | 406.55M | 404.12M | 402.39M | 357.07M |
| Retained Earnings | -560.75M | -443.66M | -419.06M | -401.44M | -345.94M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -49.11M | -37.11M | -14.95M | 949.00K | 11.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -49.11M | -37.11M | -14.95M | 949.00K | 11.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -49.11M | -37.11M | -14.95M | 949.00K | 11.13M |
|
|
|||||